Advertisement

Archives of Gynecology and Obstetrics

, Volume 298, Issue 1, pp 147–156 | Cite as

Breast cancer patients’ satisfaction with individual therapy goals and treatment in a standardized integrative medicine consultancy service

  • Carolin C. Hack
  • Sophia Antoniadis
  • Janina Hackl
  • Hanna Langemann
  • Judith Schwitulla
  • Peter A. Fasching
  • Matthias W. Beckmann
  • Anna-Katharin Theuser
Gynecologic Oncology

Abstract

Purpose

Complementary medicine services are nowadays usually quite heterogeneous, and little information is available on standards for running an integrative medicine consultancy service. This study aimed to assess patients’ satisfaction with a standardized treatment service on integrative medicine.

Methods

Using a cross-sectional design, 75 breast cancer patients from the integrative medicine consultancy service at the University Breast Center for Franconia were evaluated between January 2016 and March 2017. At primary consultation, patients answered a standardized questionnaire on their medical history and treatment goals regarding integrative medicine. In a subsequent interview, patients evaluated their satisfaction with the treatment service and individual treatment goals.

Results

72% of the patients (n = 54) reported high satisfaction with the overall approach of the treatment service. 76% of the patients (n = 57) were very satisfied or satisfied with their individual treatment plans. The most frequently reported goals were to slow tumor progression (n = 64, 85.3%), reducing the side effects of conventional cancer treatments (n = 60, 80%), and a desire to participate actively in the treatment of breast cancer (n = 64, 85.3%).

Conclusions

Using a standardized procedure in integrative medicine allows a high quality level to be offered to patients. Overall, breast cancer patients report very high satisfaction with the integrative medicine consultancy service and state long-term treatment goals. Hence, long-term treatment with integrative medicine methods should be taken into consideration.

Keywords

Breast cancer Oncology Integrative medicine Complementary and alternative medicine Consultancy service Consultation 

Abbreviations

CAM

Complementary and alternative medicine

IMed

Integrative medicine

TCM

Traditional Chinese medicine

Notes

Acknowledgements

We would like to express our thanks to all of the patients and staff who participated in the study. The contribution of A.K. Theuser to this publication was made in partial fulfillment of the requirements for obtaining the doctoral degree “Dr. rer. biol. hum.”. Parts of the research published here have been used for her doctoral thesis in the Medical Faculty of Friedrich Alexander University of Erlangen-Nuremberg (FAU).

Author contributions

CCH, TAK and MWB contributed to the conception of the current analysis, and all authors were involved in the design and acquisition of data from the study. TAK and JS performed the statistical analysis. CCH, TAK, and PAF contributed to the analysis and the interpretation of the data. CCH and TAK drafted the manuscript, and all authors revised the final draft critically for important critical content. All authors have given final approval of the version to be published.

Funding

There was no funding for the study.

Compliance with ethical standards

Conflict of interest

PAF is a consultant with Amgen, Pfizer, Roche and Novartis. This is not related to any of the topics presented in this article. All other authors hereby declare that there are no conflicts of interest.

Ethical approval

All procedures performed in the survey involving human participants were in accordance with the ethical standards of institutional and national research committee. This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the survey.

References

  1. 1.
    Hack CC, Hüttner NBM, Paepke D et al (2014) Integrative Medizin in der Gynäkologischen Onkologie—Möglichkeiten und Grenzen Teil 1. Senologie Zeitschrift für Mammadiagnostik und therapie 11:217–226CrossRefGoogle Scholar
  2. 2.
    The Bravewell Collaborative (2016). http://www.bravewell.org/integrative_medicine/. Accessed 24 Jul 2016
  3. 3.
    Horneber M, Bueschel G, Dennert G et al (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11:187–203CrossRefPubMedGoogle Scholar
  4. 4.
    Molassiotis A, Browall M, Milovics L et al (2006) Complementary and alternative medicine use in patients with gynecological cancers in Europe. Int J Gynecol Cancer 16(Suppl 1):219–224CrossRefPubMedGoogle Scholar
  5. 5.
    Munstedt K, Kirsch K, Milch W et al (1996) Unconventional cancer therapy—survey of patients with gynaecological malignancy. Arch Gynecol Obstet 258:81–88PubMedGoogle Scholar
  6. 6.
    Molassiotis A, Scott JA, Kearney N et al (2006) Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 14:260–267CrossRefPubMedGoogle Scholar
  7. 7.
    DiGianni LM, Garber JE, Winer EP (2002) Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20:34S–38SPubMedGoogle Scholar
  8. 8.
    Leitlinienprogramm Onkologie der AWMF DKeVuDKeV (2012) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. In: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF) e.VGoogle Scholar
  9. 9.
    Hack CC, Fasching PA, Fehm T et al (2016) Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients in the EvAluate-TM study. Integr Cancer Ther.  https://doi.org/10.1177/1534735416668575 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Gerber B, Scholz C, Reimer T et al (2006) Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat 95:199–209CrossRefPubMedGoogle Scholar
  11. 11.
    Paul M, Davey B, Senf B et al (2013) Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol 139:1515–1522CrossRefPubMedGoogle Scholar
  12. 12.
    Tautz E, Momm F, Hasenburg A et al (2012) Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study. Eur J Cancer 48:3133–3139CrossRefPubMedGoogle Scholar
  13. 13.
    Fasching PA, Thiel F, Nicolaisen-Murmann K et al (2007) Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer 15:1277–1284CrossRefPubMedGoogle Scholar
  14. 14.
    Wanchai A, Armer JM, Stewart BR (2010) Complementary and alternative medicine use among women with breast cancer: a systematic review. Clin J Oncol Nurs 14:E45–E55CrossRefPubMedGoogle Scholar
  15. 15.
    Huebner J, Rose C, Geissler J et al (2014) Integrating cancer patients’ perspectives into treatment decisions and treatment evaluation using patient-reported outcomes—a concept paper. Eur J Cancer Care (Engl) 23:173–179CrossRefGoogle Scholar
  16. 16.
    Huebner J, Muenstedt K, Prott FJ et al (2014) Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care (Basel) 9:60–63CrossRefGoogle Scholar
  17. 17.
    Huebner J, Micke O, Muecke R et al (2014) User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer Res 34:943–948PubMedGoogle Scholar
  18. 18.
    Nicolaisen-Murmann K, Thiel F, Mohrmann S et al (2005) Complementary and alternative medicine in women with gynecological and breast malignancies—a multicenter study exploring prevalence and motivation. Geburtsh Frauenheilk 65:178–185CrossRefGoogle Scholar
  19. 19.
    Koehl B, Muenstedt K, Micke O et al (2014) Survey of German non-medical practitioners regarding complementary and alternative medicine in oncology. Oncol Res Treat 37:49–53CrossRefPubMedGoogle Scholar
  20. 20.
    Hack CC, Hüttner NB, Fasching PA et al (2015) Development and validation of a standardized questionnaire and standardized diary for use in integrative medicine consultations in gynecologic oncology. Geburtshilfe Frauenheilkd 75:377–383CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Wilson AR, Marotti L, Bianchi S et al (2013) The requirements of a specialist Breast Centre. Eur J Cancer (Oxf Engl 1990) 49:3579–3587CrossRefGoogle Scholar
  22. 22.
    Kim CE, Shin JS, Lee J et al (2017) Quality of medical service, patient satisfaction and loyalty with a focus on interpersonal-based medical service encounters and treatment effectiveness: a cross-sectional multicenter study of complementary and alternative medicine (CAM) hospitals. BMC Complement Altern Med 17:174CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Hack CC, Beckmann MW, Hein A et al (2014) Einsatz von integrativen Heilmethoden durch postmenopausale Mammakarzinompatientinnen in der PreFace Phase IV Studie—eine prospektive, longitudinale Untersuchung. Geburtshilfe und Frauenheilkunde 74:PO_Onko10_19Google Scholar
  24. 24.
    Deng GE, Frenkel M, Cohen L et al (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7:85–120PubMedGoogle Scholar
  25. 25.
    Greenlee H, Balneaves LG, Carlson LE et al (2014) Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 2014:346–358CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Sundberg T, Halpin J, Warenmark A et al (2007) Towards a model for integrative medicine in Swedish primary care. BMC Health Serv Res 7:107CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Cramer H, Cohen L, Dobos G et al (2013) Integrative oncology: best of both worlds—theoretical, practical, and research issues. Evid Based Complement Altern Med 2013:383142Google Scholar
  28. 28.
    Hannover MH (2015) ZAP satisfaction in outpatient care—quality from the patient's perspective. National Assoc Statutory Health Insurance Phys (KBV)Google Scholar
  29. 29.
    Kilian R, Gonnerman C, Seiler R et al (2009) The development of a questionnaire for the assessment of integrated health-care programmes from the patients’ perspective (BIGPAT). Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 71:460–468CrossRefGoogle Scholar
  30. 30.
    Scholl I, Hölzel L, Härter M et al (2011) Fragebogen zur zufriedenheit in der ambulanten versorgung–schwerpunkt patientenbeteiligung (ZAPA). Klinische Diagnostik und Evaluation 4:50–62Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-European Metropolitan Area Nuremberg (CCC ER-EMN), Erlangen University HospitalFriedrich Alexander University of Erlangen-NurembergErlangenGermany

Personalised recommendations